Talecris Biotherapeutics Holdings Corporation
The Shuman Law Firm is investigating potential claims against the board of directors of Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) related to the Company’s agreement to be acquired by Grifols, S.A.
If you currently own shares of Talecris and are interested in discussing your rights as a Talecris shareholder, or have information relating to this investigation, please contact Kip B. Shuman or Rusty E. Glenn toll free at (866) 974-8626 or email Mr. Shuman at kip@shumanlawfirm.com or Mr. Glenn at rusty@shumanlawfirm.com.
|
|